Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Clear Sky Recovery's World Renowned Ibogaine Treatment Program
  • USA - English


News provided by

iReachCompany

Jun 14, 2018, 07:00 ET

Share this article

Share toX

Share this article

Share toX


MIAMI, June 14, 2018 /PRNewswire-iReach/ -- Clear Sky Recovery, the world's foremost experts in medically-based ibogaine treatment -- and one of the world's leading top-tier substance abuse treatment centers – has been spearheading ibogaine research, medical development, and treatment protocols for over twenty years.

Ibogaine is a naturally-occurring, plant-based medicine, which has been shown to alleviate upwards of 95% of withdrawal symptoms and interrupt the process of active addiction. It provides a painless and very rapid detox from opiates and opioids, stimulants, as well as alcohol and many other addictive drugs. Ibogaine is not a maintenance medication or substitution therapy, which replaces one highly-addictive molecule, with another equally or more addicting drug, which happens to be legal. Ibogaine works differently than other drug treatments, it provides efficacy in a single-administration modality (SAM).

Quote Text

Post this

Our scientists, researchers, and clinicians working with ibogaine to interrupt polysubstance abuse disorders, have spent decades of time evolving and fine-tuning our ibogaine treatment protocols and are very familiar with the pharmacokinetics and pharmacodynamics of ibogaine and its interaction with a broad spectrum of molecules such as heroin, OxyContin, cocaine, methamphetamine, and other drugs. We structure our ibogaine treatment protocols based upon the best possible response to a given situation. Each treatment episode is custom-tailored and optimized for the medical condition and unique situation of the individual receiving ibogaine treatment.

America's opioid epidemic has reached catastrophic levels, with absolutely no effective solutions available. The situation has resulted in a lack of options for US-based residents in need of alternative, holistic drug treatment that actually works. Clear Sky Recovery's medically-based, clinically-managed, state-of-the-art, oceanfront private hospital in beautiful Cancun Mexico, was established to provide a luxurious yet cost-effective solution for patients who may have met with failure utilizing more conventional detox methodologies.

Our ibogaine safety protocols and drug-interaction database are extensive and greatly exceed the resources available to any other ibogaine detox clinic. We have access to the world's largest database of ibogaine treatment episodes, dating back to the early-1990s and the work done at the University of Miami's, Ibogaine Research Project, and Healing Visions Institute for Addiction Recovery, Ltd., at the St. Kitts research facility, West Indies.

Members of our team, under the leadership of Dr. Deborah Mash, developed the ibogaine treatment safety protocols which are foundational for all medically-based ibogaine treatment, in order to gain FDA approval to test on human subjects. Our group did all of the initial pharmacokinetic research on ibogaine metabolism in human, drug-dependent subjects, discovered ibogaine's long-acting metabolite noribogaine, and proved efficacy of ibogaine in heroin withdrawal.

We are the only ibogaine treatment facility in the world whose founders and consultants are regularly published in peer-reviewed medical journals . We do evidence-based treatment predicated on the science behind ibogaine. We only engage in marketing based upon best medical practices. We will provide you with the safest, most effective ibogaine detoxification humanly possible.

While research is ongoing and countries such as Brazil now offer government-approved, medically-supervised ibogaine treatment, no such options are available to US residents in need of effective medication for treatment of drug dependence disorders.

"Unlike Clear Sky Recovery, many dishonest and self-styled Ibogaine clinics administer the drug in unsafe settings. Patients seeking Ibogaine treatment must be cautious before traveling abroad to take the drug without careful review of the program and the people behind it," warns neuroscientist Dr. Deborah Mash, the world's foremost scientific expert on ibogaine, in her recent paper, Breaking the cycle of opioid use disorder with Ibogaine, in The American Journal of Drug and Alcohol Abuse's, Jan 2018 issue. Dr. Mash highlights a recent 2017 ibogaine fatality in New Zealand, in a MAPS funded ibogaine study, and the haphazard methodology employed by unskilled lay providers on Mexico's west coast. "This recent death underscores the persistent problem associated with the use of ibogaine in unregulated, nonmedical settings by unqualified persons. Ibogaine has complicated pharmacokinetics that contribute to concerns for careful dosing, potential drug interactions, and issues of cardiovascular safety."

Clear Sky Recovery is owned and operated by medical director Dr. Alberto Sola, it was co-founded by neuroscientist Dr. Deborah Mash, the only researcher in history ever granted FDA approval to conduct pharmacokinetic and safety trials with ibogaine on human drug-dependent subjects within the United States

For more information, please visit https://clearskyibogaine.com

About Clear Sky Recovery

Clear Sky Recovery offers a luxurious, medically-based, safe, effective and affordable, ibogaine detoxification program in a private oceanfront hospital located in beautiful Cancún, Mexico.

Media Contact: Laura Shapiro, Clear Sky Recovery, (305) 901-5371, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE Clear Sky Recovery

iReach LastName, iReachCompany, 111-222-3333, [email protected]

Modal title

Clear Sky Recovery
Clear Sky Recovery
Clear Sky Recovery

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.